Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
10,076,433
-
Share change
-
-416,573
-
Total reported value
-
$40,304,200
-
Price per share
-
$4.00
-
Number of holders
-
37
-
Value change
-
-$3,171,773
-
Number of buys
-
14
-
Number of sells
-
17
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q1 2017
As of 31 Mar 2017 Xenon Pharmaceuticals Inc. - Common Stock (XENE) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,076,433 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Capital World Investors, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., Invesco Private Capital, Inc., Opaleye Management Inc., Tekla Capital Management LLC, Endurant Capital Management LP, and DAFNA Capital Management LLC.
This table shows 37 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.